Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Eli Lilly
Pharmaceuticals
Obesity
Mounjaro
GSK
AstraZeneca
Johnson and Johnson
Novo Nordisk
Sanofi
Novartis
Amycretin
Topics

Advertisement

Eli Lilly

Share

Top Latest Popular

🐣 SPRING OFFER! Go ad free with NewsNow Essentials at just £2.99/m!

🐣 SPRING OFFER! Stay informed ad free with NewsNow Essentials at just £2.99 a month!

Why Eli Lilly stock climbed to a new all-time high today The Motley Fool 20h

The Motley Fool 20h

Novo Nordisk Obesity

Lilly shares jump as analysts see retatrutide data extending obesity market edge BNN Bloomberg 1d

BNN Bloomberg 1d

Tirzepatide Obesity

Lilly just announced 3 infectious disease acquisitions in 1 day. Is this the beginning of its post-obesity growth strategy? The Motley Fool 1d

The Motley Fool 1d

Mounjaro Pharma

Advertisement

Advertisement

Eli Lilly's retatrutide achieves 28% weight loss in Phase III trial Manufacturing Chemist 15:21 Thu, 21 May

Manufacturing Chemist 15:21 Thu, 21 May

Obesity The Lancet

Eli Lilly continues genetic medicine push with $1.9bn Ascidian partnership Pharmaceutical Technology 5d

Pharmaceutical Technology 5d

Ascidian Pharma

Eli Lilly highlights weight loss benefits for women across menopausal stages Benzinga 1d

Benzinga 1d

Menopause Reproductive Health

Advertisement

Advertisement

Latest

In the last 6 hours

Can Eli Lilly's Clinical Momentum Keep the Stock at Record Highs? Zacks 16:58

In the last 8 hours

AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn Manufacturing Chemist 16:07

Alzecure enters collaboration and with Lilly for Alzheimer’s project PharmaTimes 15:02

Earlier Today

Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up Rock Hill Herald 12:13

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions Business Wire (Press Release) 09:00

Roche sticks to German investment after Eli Lilly cuts Rock Hill Herald 09:00

Eli Lilly Conspiracy Claim In Compound Drug Row Challenged Law360 03:27

Why Eli Lilly Stock Climbed to a New All-Time High Today The Motley Fool 02:15

Yesterday

Lilly Just Announced 3 Infectious Disease Acquisitions in 1 Day. Is This the Beginning of Its Post-Obesity Growth Strategy? The Motley Fool 22:51 Mon, 08 Jun

AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial Rock Hill Herald 21:37 Mon, 08 Jun

Advertisement

Advertisement

Advertisement

About our Eli Lilly news

Latest news on on Eli Lilly and Company, an American pharmaceutical with headquarters in Indianapolis.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Industry Sectors Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis